Javascript must be enabled to continue!
Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany
View through CrossRef
Abstract
Background
Pre-exposure prophylaxis (PrEP) with oral emtricitabine/tenofovir disoproxil (FTC/TDF) proved highly efficient in preventing HIV. Since 09/2019, FTC/TDF-PrEP is covered by health insurances in Germany, if prescribed by licensed specialists. However, methods to longitudinally monitor progress in PrEP implementation in Germany are lacking.
Methods
Utilizing anonymous FTC/TDF prescription data from 2017–2021, we developed a mathematical model to disentangle HIV-treatment from PrEP prescriptions, as well as to translate PrEP prescriptions into number of PrEP users. We used the model to estimate past- and future PrEP uptake dynamics, to predict coverage of PrEP needs and to quantify the impact of COVID-19 on PrEP uptake on a national and regional level.
Results
We identified significant (p < 0.01) decelerating effects of the first- and second COVID-19-lockdown on PrEP uptake in 04/2020 and 12/2020. We estimated 26,159 (CI: 25,751 − 26,571) PrEP users by 12/2021, corresponding to 33% PrEP coverage of people in need. We projected 64,794 (CI: 62,956 − 66,557) PrEP users by 12/2030, corresponding to 67% PrEP coverage. We identified profound regional differences, with high PrEP coverage and uptake in metropoles and low coverage in more rural regions.
Conclusions
Our approach presents a comprehensive solution to monitor and forecast PrEP implementation from anonymous data and highlighted that the COVID-19 pandemic significantly decelerated PrEP uptake in Germany. Moreover, slow PrEP uptake in rural areas indicate that structural barriers in PrEP care, education or information exist that may hamper the goal of ending the AIDS epidemic by 2030.
Research Square Platform LLC
Title: Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany
Description:
Abstract
Background
Pre-exposure prophylaxis (PrEP) with oral emtricitabine/tenofovir disoproxil (FTC/TDF) proved highly efficient in preventing HIV.
Since 09/2019, FTC/TDF-PrEP is covered by health insurances in Germany, if prescribed by licensed specialists.
However, methods to longitudinally monitor progress in PrEP implementation in Germany are lacking.
Methods
Utilizing anonymous FTC/TDF prescription data from 2017–2021, we developed a mathematical model to disentangle HIV-treatment from PrEP prescriptions, as well as to translate PrEP prescriptions into number of PrEP users.
We used the model to estimate past- and future PrEP uptake dynamics, to predict coverage of PrEP needs and to quantify the impact of COVID-19 on PrEP uptake on a national and regional level.
Results
We identified significant (p < 0.
01) decelerating effects of the first- and second COVID-19-lockdown on PrEP uptake in 04/2020 and 12/2020.
We estimated 26,159 (CI: 25,751 − 26,571) PrEP users by 12/2021, corresponding to 33% PrEP coverage of people in need.
We projected 64,794 (CI: 62,956 − 66,557) PrEP users by 12/2030, corresponding to 67% PrEP coverage.
We identified profound regional differences, with high PrEP coverage and uptake in metropoles and low coverage in more rural regions.
Conclusions
Our approach presents a comprehensive solution to monitor and forecast PrEP implementation from anonymous data and highlighted that the COVID-19 pandemic significantly decelerated PrEP uptake in Germany.
Moreover, slow PrEP uptake in rural areas indicate that structural barriers in PrEP care, education or information exist that may hamper the goal of ending the AIDS epidemic by 2030.
Related Results
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial
Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial
Background
Vulnerable adolescents and emerging adults (aged 18-29 years), particularly young transgender women, are among the fastest-growing HIV positive popul...
Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial (Preprint)
Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial (Preprint)
BACKGROUND
Vulnerable adolescents and emerging adults (aged 18-29 years), particularly young transgender women, are among the fastest-growing HIV positive p...
336 Bowel Preparation for Patients With History of Inadequate Cleansing With 4L PEG-3350 (Golytely) Split-Prep: The 6 Liter PEG-3350 (Golytely®) Split-Prep
336 Bowel Preparation for Patients With History of Inadequate Cleansing With 4L PEG-3350 (Golytely) Split-Prep: The 6 Liter PEG-3350 (Golytely®) Split-Prep
INTRODUCTION:
No prior prospective study has assessed the efficacy of a more intensive bowel preparation (prep) for outpatients who have already failed a 4 lite...
Primary care provider prep prescribing practices : southern United States
Primary care provider prep prescribing practices : southern United States
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African Americans make up the majority of new HIV diagnoses in this region. Pre-Exposure...
1270. Population-Based Estimates of PrEP Access in Oregon, 2012–2016
1270. Population-Based Estimates of PrEP Access in Oregon, 2012–2016
Abstract
Background
PrEP is an important HIV prevention modality. Population-based metrics of PrEP uptake and access are critica...

